LANXESS (LXS) Panoramica del titolo
LANXESS Aktiengesellschaft, insieme alle sue consociate, opera come società di specialità chimiche che si occupa dello sviluppo, della produzione e della commercializzazione di intermedi chimici, additivi, specialità chimiche e prodotti per la protezione dei consumatori in tutto il mondo. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 5/6 |
| Crescita futura | 0/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 3/6 |
| Dividendi | 0/6 |
LXS Community Fair Values
Create NarrativeSee what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di LANXESS Aktiengesellschaft
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | €16.19 |
| Massimo di 52 settimane | €27.14 |
| Minimo di 52 settimane | €11.03 |
| Beta | 1.14 |
| Variazione di 1 mese | -1.88% |
| Variazione a 3 mesi | -11.96% |
| Variazione di 1 anno | -37.78% |
| Variazione a 3 anni | -41.34% |
| Variazione a 5 anni | -72.58% |
| Variazione dall'IPO | 9.10% |
Notizie e aggiornamenti recenti
Articolo di analisi • Jun 20
LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts
LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...
Aggiornamento della narrazione • Jun 17
LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk
The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.
Aggiornamento della narrazione • Jun 02
LXS: Fair Outlook Flags Limited Upside As Middle East Risk Deepens
LANXESS's fair value estimate is revised from €14.0 to €11.0 as analysts reset price targets following multiple downgrades, citing limited perceived upside after the share price rally, along with fresh concerns around pricing, demand resilience, and the balance sheet linked to the Middle East conflict. Analyst Commentary Recent research updates on LANXESS point to a clear shift toward caution, with several large houses cutting ratings and trimming price targets.Recent updates
Articolo di analisi • Jun 20
LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts
LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...Aggiornamento della narrazione • Jun 17
LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk
The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.Aggiornamento della narrazione • Jun 02
LXS: Fair Outlook Flags Limited Upside As Middle East Risk Deepens
LANXESS's fair value estimate is revised from €14.0 to €11.0 as analysts reset price targets following multiple downgrades, citing limited perceived upside after the share price rally, along with fresh concerns around pricing, demand resilience, and the balance sheet linked to the Middle East conflict. Analyst Commentary Recent research updates on LANXESS point to a clear shift toward caution, with several large houses cutting ratings and trimming price targets.Articolo di analisi • May 09
Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...Aggiornamento della narrazione • May 01
LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E
Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
Aggiornamento della narrazione • Apr 16
LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk
LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.Aggiornamento della narrazione • Apr 02
LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk
Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.Aggiornamento della narrazione • Mar 19
LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade
Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.Aggiornamento della narrazione • Mar 05
LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential
Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.Aggiornamento della narrazione • Feb 18
LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing
LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.Aggiornamento della narrazione • Feb 04
LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing
Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.Aggiornamento della narrazione • Jan 21
LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades
Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.Aggiornamento della narrazione • Jan 06
LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing
Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.Articolo di analisi • Jan 02
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...Aggiornamento della narrazione • Dec 17
LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing
Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.Articolo di analisi • Dec 15
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Aggiornamento della narrazione • Dec 03
LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution
The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.Aggiornamento della narrazione • Nov 19
LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance
LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.Aggiornamento della narrazione • Nov 05
LXS: Future Resilience Will Support Stability Amid Sector Pressures
Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.Aggiornamento della narrazione • Oct 22
Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts
The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.Aggiornamento della narrazione • Oct 08
Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities
The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.Aggiornamento della narrazione • Aug 29
Accelerated FORWARD! Program Set To Improve Future Performance
Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.Articolo di analisi • Jul 03
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
Nuova narrazione • Mar 22
Accelerated FORWARD! Program Set To Improve Future Performance
Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.Articolo di analisi • Mar 07
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...Articolo di analisi • Jan 31
LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Articolo di analisi • Jan 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Articolo di analisi • Oct 30
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Articolo di analisi • Sep 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Articolo di analisi • Jul 23
Is LANXESS (ETR:LXS) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Articolo di analisi • May 27
Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...Articolo di analisi • May 08
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...Articolo di analisi • Apr 20
Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...Articolo di analisi • Mar 22
Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Jan 27
What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Articolo di analisi • Dec 05
Is LANXESS (ETR:LXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Nov 01
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €20.51 based on Dividend Discount Model Current share price of...Rendimenti per gli azionisti
| LXS | DE Chemicals | DE Mercato | |
|---|---|---|---|
| 7D | -6.3% | -1.7% | -1.7% |
| 1Y | -37.8% | 1.6% | -0.6% |
Ritorno vs Industria: LXS ha avuto una performance inferiore rispetto al German Chemicals che ha registrato un rendimento 1.6 % nell'ultimo anno.
Rendimento vs Mercato: LXS ha avuto una performance inferiore al mercato German che ha registrato un rendimento -0.6 % nell'ultimo anno.
Volatilità dei prezzi
| LXS volatility | |
|---|---|
| LXS Average Weekly Movement | 6.3% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in DE Market | 13.4% |
| 10% least volatile stocks in DE Market | 2.8% |
Prezzo delle azioni stabile: LXS non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato German.
Volatilità nel tempo: La volatilità settimanale ( 6% ) di LXS è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1863 | 11,630 | Matthias Zachert | lanxess.com |
LANXESS Aktiengesellschaft, insieme alle sue consociate, è un'azienda di specialità chimiche che si occupa dello sviluppo, della produzione e della commercializzazione di intermedi chimici, additivi, specialità chimiche e prodotti per la protezione dei consumatori in tutto il mondo. Opera attraverso tre segmenti: Protezione del consumatore, Additivi speciali e Intermedi avanzati. Il segmento Consumer Protection fornisce prodotti per la protezione dei materiali; soluzioni per la disinfezione, l'igiene e la conservazione; aromi e fragranze; tecnologie per la purificazione dei liquidi per il trattamento dell'acqua e di altri liquidi; precursori e intermedi per i settori agrochimico, farmaceutico e dei prodotti chimici speciali.
LANXESS Aktiengesellschaft Riepilogo dei fondamenti
| LXS statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | €1.40b |
| Utili (TTM) | -€661.00m |
| Ricavi(TTM) | €5.45b |
0.3x
Rapporto P/S-2.1x
Rapporto P/ELXS è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| LXS Conto economico (TTM) | |
|---|---|
| Ricavi | €5.45b |
| Costo del fatturato | €4.38b |
| Profitto lordo | €1.07b |
| Altre spese | €1.73b |
| Utili | -€661.00m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
Aug 07, 2026
| Utile per azione (EPS) | -7.66 |
| Margine lordo | 19.65% |
| Margine di profitto netto | -12.13% |
| Rapporto debito/patrimonio netto | 71.7% |
Come si è comportato LXS nel lungo periodo?
Vedi performance storica e confrontoDividendi
0.6%
Rendimento attuale del dividendo-1%
Rapporto di remunerazioneAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/06/28 02:44 |
| Prezzo dell'azione a fine giornata | 2026/06/26 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
LANXESS Aktiengesellschaft è coperta da 32 analisti. 15 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| James Knight | Barclays |
| Anil Shenoy | Barclays |
| Andres Castanos-Mollor | Berenberg |